Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 307-314

  Walch, E Timothy ^a   Marchetti, Dario ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Heparanase; Invasion; Neurotrophins; p75 neurotrophin receptor (p75(NTR)); Prostate cancer

Indexed keywords

HEPARANASE; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; BETA GLUCURONIDASE; GLYCOSIDASE; NERVE GROWTH FACTOR RECEPTOR; PRIMER DNA;

ARTICLE; CANCER CELL; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; METASTASIS; PROSTATE CANCER; AGAR GEL ELECTROPHORESIS; BIOSYNTHESIS; CANCER INVASION; CELL CULTURE; ENZYMOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; DNA PRIMERS; ELECTROPHORESIS, AGAR GEL; GLUCURONIDASE; GLYCOSIDE HYDROLASES; HUMANS; MALE; NEOPLASM INVASIVENESS; NERVE GROWTH FACTORS; PROSTATIC NEOPLASMS; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0032589782     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006652605568     Document Type: Article

References (59)

1. Gloeckler Reis LA, Hunkey BF, Edwards BK (eds). Cancer Statistics View, 1973-1987, Bethesda, MD: The Surveillance Program-DCPC, NIH, US Department of Health and Human Services 1990; 1-357.
2. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate 1990; 16:39-48.
3. Cunha GR. The role of androgens in epithelio-mesenchymal inter-actionsinvolved in prostatic morphogenesis in embryonic mice. Anal Ree 1980; 175:87-96.
4. Cunha GR, Clung LWK, Shannon JM, Reese BA, Stromal-epithelial interactions in sex differentiation. Biol Reprod 1980; 22: 19-42.
5. Chung GR, Cunha GR. Stromal-epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate 1983; 4: 503-11.
6. Sugimura Y, Cunha GR, Donjour A et al. Whole autoradiography study of DNA synthetic activity during postnatal development and induced regeneration in the mouse prostate. Biol Reprod 1986; 34: 985-95.
7. Sugimura Y, Norman JT, Cunha GR, Shannon JM. Regional differences in the inductive activity of the mesenchyme of the embryonic mouse urogenital sinus, Prostate 1985; 7: 253-60.
8. Djakiew D, Delsite R, Pflug B et al. Regulation of growih by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res 1901; 51: 3304-10.
9. Harper GP, Barde YA, Burnstock YA et al. Guinea pig prostate is a rich source of nerve growth factor. Nature 1979; 279: 160-3.
10. Harper GP, Thoenen H. The purification of nerve growth factor from bovine seminal plasma, J Neurochem 1980; 34: 893-903.
11. Graham C, Lynch JH, Djakiew D. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urol 1992; 147: 1444-7.
12. MacGrogan D, Saint-Andre J-P, Dicou R. Expression of nerve growth factor receptor genes in human tissues and in prostatic adenoearci-noma cell lines. J Neurochem 1992; 59: 1381-91.
13. Shikata H, Uisumi N, Hiramatsu M et al. Immunohistochemical localization of nerve growth factor and epidermal growth factor in guinea pig prostate gland. Histochemistry 1984; 80; 4.111-3.
14. Murphy RA, Watson AY, Rhodes JA. Biological sources of nerve-growth factor. Appl Neurophysiol 1984; 47: 33-42.
15. Levi-Montalcini R, The nerve growth factor 35 years later. Science 1987; 237: 1154-64.
16. Ip NY, Yancopoulos G. Neurotrophic factors and their receptors. Prog Brain Res 1995; 105: 189-95.
17. Snider WD. Functions of the neurotrophins during nervous system development: what knockouts are teaching us. Cell 1994; 77: 627-38.
18. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci 1995; 18: 223-53.
19. Chao MV. Neurotrophin receptors: a window into neuronal differentiation. Neuron 1992; 9: 583-93.
20. Barbacid M. Structural and functional properties of the Trk family of neurotrophin receptors. Ann NY Acad Sci 1995; 766: 442-58.
21. Marchetti D, Menter DG, Jin L et al. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int J Cancer 1993; 55: 692-9.
22. Marchetti D, McCutcheon I, Ross HM, Nicolson GL. Inverse expression of neurotrophin receptor and neurotrophins at the invasion front of brain-metastatic human melanoma tissues. Im J Oncol 1995; 7: 87-94.
23. Nicolson GL, Monter DG, Herrmann JL, et al. Tumor metastasis to brain: role of endothelial cells, neurotrophins, and paracrine growth factors. Crit Rev Oncogenesis 1994; 5: 451-71.
24. Herrmann JL, Mentor DG, Hamada J et al. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell 1993; 4: 1205-16.
25. Marchetti D, Parikh N, Sudol M, Gallick GE. Stimulation of the protein tyrosine kinase c-Yes but not c-Sre by neurotrophins in human brain-metastatic melanoma cells. Oncoyene 1998; 16: 3253-60.
26. Marchetti D, McQuillan D, Spohn WC et al. Neurotrophin stimulation of human melanoma cell invasion: Selected NT enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations. Cancer Res 1996; 56: 2856-63.
27. Marchetti D. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases. J Cell Physiol 1997; 172:334-42.
28. Nicolson GL, Nakajima M, Herrmann JL et al. Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors. J Neurooncol 1994; 18: 139-49.
29. DeSchryver-Kecskemeti K, Balogh K, Neet KE. Nerve growth factor and the concept of neural-epithelial interactions. Arch Pathol Lab Med 1987; 111: 833-5.
30. Persson H, Ayer-Lievre C, Soder O et al. Expression of beta-nerve growth factor receptor mRNA in Sertoli cells downregulated by testosterone. Science 1990; 247: 704-8.
31. Djakiew D, Pflug BR, Delsite R et al. Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 1993; 53: 1416-20.
32. Chung LWK, Li W, Gleuvo ME et al. Human prostate cancer model: roles of growth factors and extracellular matrices. J Cell Biochem 1992; 16H: 99-105.
33. MacGrogan D, Saint-Andre JP, Dicou E. Expression of nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines. J Neurochem 1992; 34: 1381-91.
34. Ip NY, Ibanez CF, Nye SH et al. Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Nail Acad Sci USA 1992; 89: 3060-64.
35. Graham CW, Lynch JH, Djakiew D. Distribution of nerve growth factor-like protein and nerve growth factor receptor in human benign prostatic hyperplasia and prostatic adenocarcinoma. J Urology 1992; 147: 1444-47.
36. Pflug RR, Onoda M, Lynch JH, Djakiew D. Reduced expression of the low-affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metaslatic prostate tumor cell lines. Cancer Res 1992; 52: 5403-6.
37. Pflug DR, Dionne C, Kaplan DR et al. Expression of a Trk high affinity nerve growth factor receptor in the human prostate. Endocrinology 1995; 136: 262-8.
38. Angelsen A, Sandvik AK, Syrensen U et al. NGF-β, NE-cells and prostatic cancer cell lines. Scan J Urol Nephrol 1998; 32: 7-13.
39. Cunha OR, Chung LWK, Shannon JM et al. Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. Recent Progr Horm Res 1983; 51: 3304-10.
40. Kawaja MD, Crutcher KA. Sympathetic axons invade the brains of mice overexpressing nerve growth factor. J Comp Neurol 1997; 383: 60-72.
41. Ware JL, Maygarden SJ. Metastatic diversity in human prostatic carcinoma: implications of growth factor receptors for the metastatic phenotype. Pathol Immunopathol Res 1989; 8: 231-8.
42. Papandreou C, Bogenrieder T, Loganzo F. Mutation and expression of the low-affinity neurotrophin receptor in human malignant melanoma. Melanoma Res 1996; 6: 373-8.
43. Navone NM, Olive M, Ozen M et al. Establishment of two human prostate cancer cell lines derived from a single hone metastasis. Clin Cancer Res 1997; 3: 2493-500.
44. Greco A, Villa R, Pierotti M. Genomic organization of the human NTRK1 gene, Oncogene 1996; 13: 2463-6.
45. Ichaso N, Rodriguez RE, Martin-Zanca D, Gonzalez-Sarmiento R. Genomic characterization of the human trkC gene. Oncogenc 1998; 17: 1871-5.
46. Albini A, Iwamoto Y, Kleinmann HK et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
47. Paul AB, Grant ES, Habib FK. The expression and localisation of β-nerve growth factor (β-NGF) in benign and malignant human prostate tissue: relationship to neuroendocrine differentiation. Br J Cancer 1996; 74: 1990-6.
48. Nakajima M, Irimuru T, Nicolson GL. Heparanase and tumor metastasis. J Cell Biochem 1986; 36: 157-67.
49. Dalal R, Djakiew D. Molecular characterization of neurotrophin expression and the corresponding tropomyosin receptor kinases (trks) in epithelial and stromal cells of the human prostate. Mol Cell Endocrinology 1997; 134: 15-22.
50. Korsching S, Auburger G, Heumann R et al. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with colinergic innervation. Eur Mol Biol Org 1985; 4: 1389-93.
51. Kosir MA, Quinn CCV, Zukowski KL et al. Human prostate carcinoma cells produce extracellular heparanase. Journ Surgical Res 1997; 67: 98-105.
52. Chang S-M, Chung LWK. Interaction between prostatic fibroblast and epithelial cells in culture: role of androgens. Endocrinology 1989; 125:2719-27.
53. Nakagawara A, Azar CG, Seavarda NJ, Brodeur CM. Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 1994; 14: 759-67.
54. Hamel W, Westphal M, Szonyi E et al. Neurotrophin gene expression by cell lines derived from human gliomas. J Neurosci Res 1993; 34: 147-57.
55. Keles GE, Berger MS, Schofield D, Bothwell M. Nerve growth factor receptor expression in medulloblasloma and the potential role of nerve growth factor as a differentiating agent in medulloblastoma cell lines. Neurosurgery 1993; 32: 274-80.
56. Missale C, Boroni F, Losa M et al. Nerve growth factor suppresses the transforming phenotype of human prolactinomns. Proc Natl Acad Sci USA 1993; 90: 7961-5.
57. Polak M, Scharfmann R, Seilheimer B el al. Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line. Proc Natl Acad Sci USA 1993; 90: 5781-5.
58. Geldof AA, De Kleijn MAT, Rao BR, Newling DWW. Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostate cancer cells. J Cancer Res Clin Oncol 1997; 123: 107-12.
59. Ibanez CF, Efbendal T, Barbany G et al. Disruption of the low-affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell 1992; 69: 329-41.